Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Lanova Medicines Zhejiang Co., Ltd., explained in plain language.
This study tests an experimental drug called LM-302 against standard treatments for people with advanced stomach or gastroesophageal junction cancer that has gotten worse after at least two prior therapies. The trial includes 387 adults whose tumors have a specific protein (CLDN1…
Phase: PHASE3 • Sponsor: LaNova Medicines Zhejiang Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC